Yahoo Web Search

  1. Ad
    related to C. R. Bard, Inc
  1. Yahoo Finance Results

  2. Becton, Dickinson (BDX) Earnings and Revenues Beat in Q3

    Zacks via Yahoo FinanceAug 02 15:38 PM

    Becton, Dickinson and Company BDX posted third-quarter fiscal 2018 earnings per share of $2.91, which beat the Zacks Consensus Estimate of $2.85. Earnings also improved 18.3% on a year-over-year ...

  3. Edited Transcript of BDX earnings conference call or presentation 2-Aug-18 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 03 15:30 PM

    Christopher R. Reidy, Becton, Dickinson and Company - Executive VP, CFO & Chief Administrative Officer [4] Thanks, Vince, and good morning, everyone.

  4. Becton, Dickinson Global Foothold Strong, Recalls Rampant

    Zacks via Yahoo FinanceAug 13 13:28 PM

    The stock currently carries a Zacks Rank #3 (Hold). Price Performance In the past year, shares of Becton, Dickinson, also known as BD, have rallied 23.5%, outperforming the industry’s rise of ...

  5. Web results

  6. Careers | Bard

    Careers at C. R. Bard, Inc. Achieve more, grow more, be more ™. As an ambitious, entrepreneurial and growing business, Bard is the natural home for driven, ethical and accountable people who want to get noticed, make things happen and enjoy the rewards they truly deserve.

  7. C. R. Bard - Wikipedia

    C. R. Bard, Inc., now branded simply as Bard, headquartered in Murray Hill, New Jersey, USA, is a leading multinational developer, manufacturer, ...

  8. Stock analysis for CR Bard Inc (BCR) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  9. C R Bard Inc 1822 Underwood Blvd Delran, NJ Physicians ...

    Get directions, reviews and information for C R Bard Inc in Delran, NJ.

  10. CR Bard | LinkedIn

    About us. Bard has joined BD. C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties.

  11. C. R. Bard, Inc. (NYSE:BCR) :: Law360

    The latest litigation news, cases and dockets involving the company C. R. Bard, Inc. (NYSE:BCR)

  12. C.R. Bard, Inc. 7/13/15 - Food and Drug Administration

    WARNING LETTER. VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED. July 13, 2015 . W/L # 27-15 . Timothy M. Ring Chairman and Chief Executive Officer C.R. Bard Inc.

  13. C.R. Bard Inc. to Pay U.S. $48.26 Million to Resolve False ...

    C.R. Bard Inc. has agreed to pay the United States $48.26 million to resolve claims that it knowingly caused false claims to be submitted to the Medicare program for brachytherapy seeds used to treat prostate cancer in violation of the False Claims Act.

  14. Bard Access Systems is an innovator and market leader in vascular access devices that have a positive impact on people's lives. We develop, manufacture and distribute medical devices including: PICCs, Ports, CVCs, Ultrasound, Midline and Dialysis Catheters, Pleural Drainage, Feeding Devices and Proceedural Accessories

  1. Ads
    related to C. R. Bard, Inc